EMJ Podcast: Insights For Healthcare Professionals

What does it take to deploy AI across national health systems? In Part 2, Vidur Mahajan shares lessons from large-scale rollouts at RadNet and Singapore's health network, covering interoperability, regulation, and success metrics.     Timestamps:   00:00 –  Introduction   00 :55  –   Deploying CARPL   05:50 – Real-world stories   10 : 52  –   Regulatory challenges   13:30 – Interoperability   16:1...

In this episode of Hema Now, we take a deep dive into myeloproliferative neoplasms  (MPN) , with a particular focus on myelofibrosis, one of the most complex and challenging MPNs to manage. Ciro Rinaldi discusses what distinguishes myelofibrosis from other chronic MPNs, the biological drivers of disease progression, and the critical role of inflammation and the bone marrow microenvironment. The co...

Vidur Mahajan joins host Catherine Glass to explore how imaging AI earns clinician trust. Learn how CARPL.ai bridges the gap between research and practice, ensures transparency, and empowers radiologists to evaluate and deploy AI safely.     Timestamps:   00:00 –  Introduction   01:0 1   –   Behind CARPL.ai   03:55 –  Addressing  scepticism   06:47 – Barriers in AI implementation   09:29  – Ensuri...

In this rapid-fire episode, Vidur Mahajan answers key questions about AI in radiology ,  from common misconceptions and bias to real-world performance, productivity tools, and what clinicians should be asking as AI enters daily imaging workflows.

Turning ideas into action, this episode focuses on how social health can be measured, funded, and implemented.  Wijedoru  discusses social prescribing, training clinicians to recognise disconnection, and simple steps individuals and organisations can take to strengthen social bonds.   Timestamps:   01:18 – Measuring social health   03:45 – Training and infrastructure   06:20 – Social prescribing  ...

How can stories heal? Wijedoru discusses how storytelling helps people feel seen and understood, why it belongs alongside data-driven medicine, and how initiatives like Behind Your Mask foster empathy and connection among healthcare professionals.   Timestamps:   01:05 – Origins of Behind Your Mask   03:30 – Why storytelling works   06:10 – Storytelling in medical culture   0 8 :00 – Tools beyond...

Nuclear medicine has undergone extraordinary transformation over the past decades, and it continues to redefine how cancer is diagnosed and treated. In this episode, Ken Herrmann reflects on his journey into nuclear medicine, the rapid evolution from PET to PET-CT, and the rise of theranostics . He discusses the balance between innovation and evidence, the growing role of multidisciplinary cancer...

In this episode, Wijedoru explains what social health really means and why it has been neglected for so long. Drawing on WHO frameworks and global experience, he explores how poor social health affects patients, communities, and healthcare systems, and why prevention must start with connection. Timestamps: 01:10 – Background 03:27 – Storytelling 05:25 – Social health 10:04 – WHO commission

Lalith Wijedoru answers rapid-fire questions on healthcare culture, loneliness, and emotional wellbeing. From lessons learned in low-resource settings to bold ideas for improving connection in hospitals, this episode introduces social health as a vital but under-recognised pillar of health.

In this final episode, Vallier explores the next steps for liver regeneration research, including stimulating liver regeneration with small molecules and lifestyle factors. He describes AI as a tool that should not be used in the wrong way, before wrapping up the discussion with his predictions for the next 5 years and the introduction of induced pluripotent stem cell clinical trials. Timestamps:...

In the second episode of the series, Vallier dives into clinical translation of research to different forms of liver disease, exploring how organoids may serve as an alternative to liver transplantation, and how immune compatibility differs between the two. Timestamps: 00:59 – Organoids versus transplantation 02:52 – Organoid immune compatibility 04:58 – Chronic liver diseases 06:15 – Clinical app...

  In this episode of Hema Now, Catherine  Glass  sits down with senior leaders from the European Association  for  Haemophilia and Allied Disorders (EAHAD) to go behind the scenes of the EAHAD 2026 Congress. The discussion explores the vision shaping the meeting, how the scientific programme is developed, and the key advances and challenges influencing haemophilia care across Europe, offering valu...

In the final podcast of this three-part series, we hear expert insights into evolving guidelines, practical tools, and multidisciplinary collaboration for the optimal diagnosis and management of RCC. Explore how healthcare professionals navigate RCC in daily practice, including the latest guidelines to the streamlining of referral pathways and evaluating treatment response.

In this first deep dive, Vallier discusses the current state of liver regeneration research. He explores how pluripotent stem cells can generate hepatocytes and biliary cells, and describes how organoids integrate into tissues whilst providing new insights into liver disease. Timestamps: 00:53 – Liver regeneration at present 03:37 – Pluripotent stem cells 05:18 – Scaling clinical use of organoids...

Ludovic Vallier joins the EMJ Podcast to answer rapid-fire questions about how regenerative technologies can be harnessed to tackle metabolic liver disease. From the biggest breakthroughs in regenerative hepatology to clinical misconceptions about stem cells, explore how this field of research is changing the liver disease landscape.

In the final episode, Gerber discusses how discoveries move from laboratory research into real-world patient care. Drawing on his experience in clinical trials, entrepreneurship, and national transplant policy, he shares insights into the future of transplantation and regenerative surgery.   Timestamps:   Pullquote and timestamps:   00:56 – Clinical  t rials   02:42 – Entrepreneurship in  l ife  s...

In this second deep dive, Gerber discusses his appointment as Chair of Surgery at the University of Cincinnati , Ohio, USA,  and his vision for advancing a century-long legacy of excellence. He reflects on how military and academic leadership shaped his approach to mentorship and accountability, explores the future of equity in surgical training, and offers advice to aspiring academic leaders.   T...

In this episode,  Robin Jones explores the complexities of sarcoma care, reflecting on his career journey, the challenges of diagnosis, and the evolving treatment landscape. The discussion spans unmet needs, promising research, and what the next decade may hold for patients with both localised and metastatic sarcoma s , drawing on experience from clinical practice and trials across the UK and USA....

In this first deep dive, Gerber explores how regenerative medicine is reshaping transplant surgery. He discusses advances in stem cell biology, tissue engineering, and  ex vivo  organ preservation, and examines how these technologies may expand organ viability and redefine surgical repair.   Timestamps:   0 1:18  –  Tissue  r egeneration    02:19  –  Evolution  b eyond  t raditional  t ransplantat...

David A. Gerber joins the EMJ Podcast for a rapid-fire discussion on what drives innovation in transplant surgery. From misconceptions about organ transplantation to the technologies shaping the future of regenerative medicine, this episode offers a concise overview of a rapidly evolving field.

In this final deep dive episode, Stuart Elborn turns to healthcare systems and policy. He discusses the importance of registries, data sharing, and service organisation, alongside social and funding factors that shape equitable cystic fibrosis care, ending with a global vision for cystic fibrosis management over the next decade. Timestamps: 00:00 – Introduction 01:08 – Healthcare delivery 03:33 –...

In this second deep dive episode, Stuart Elborn explores the future landscape of cystic fibrosis treatment beyond modulators. From mRNA and gene editing to inhaled therapies and phenotype-driven care, this episode examines how close we are to truly personalised medicine in cystic fibrosis.  Timestamps: 00:00 – Introduction 01:22 – Treatment gaps 03:13 – Extrapulmonary complications 04:14 – Novel t...

In this episode of Hema Now, Kenneth Anderson from the Dana-Farber Cancer Institute, Boston, Massachusetts,  USA, shares his expert insights in multiple myeloma research. From key takeaways from the recent  American Society of Hematology ( ASH )   C ongress to efforts tackling drug resistance, and the challenges in translating laboratory science into the clinic, this episode is a must-watch.    Ti...

The evolving understanding of OA is reshaping how we diagnose, manage, and support patients. As research advances, OA is increasingly recognised as a complex condition influenced by inflammation, biomechanics, genetics, and lifestyle. This shift in perspective is transforming how OA is identified, managed, and experienced across the care pathway. Early intervention remains essential, before irreve...